Rupee v/s Dollar Today, March 7, 2025: Rupee declines 6 Paise to ₹87.18

The rupee opened weak at the interbank foreign exchange market and fell 6 paise to ₹87.18 per dollar in early trade on Friday, March 07, 2025. It started at ₹87.13 and weakened in the early session further to ₹87.18 against the U.S. dollar. 

What Influences the Performance of the Rupee?

Forex dealers said, concerns are also weighing on the rupee, with global sentiment being lacklustre as trade-related uncertainties linger and foreign investors pull out of domestic equities. But a weakening American currency index and softer crude oil prices helped to prevent a steeper fall in the Indian currency. The dollar index, which gauges the greenback against a basket of six other currencies, fell 0.04 percent to 103.99.

Previous Rupee Performance and Market Context

On Thursday, the rupee had ascertained its three-session rising streak and settled down 6 paise at ₹ 87.12 against the US dollar. It had risen by 31 paise in the previous three straight sessions. In the home equity market, the 30-give BSE Sensex was exchanging 116.64 focuses (0.16 percent) lower at 74,223.45 focuses and Nifty was down 19.30 focuses (0.09 percent) at 22,525.40 focuses. On Thursday, foreign institutional investors (FIIs) had net sold equities worth ₹2,377.32 crore. Brent crude oil, the global benchmark, was up 0.20 percent but stayed at a six-month low of USD 69.60 per barrel in futures trading.

Trends of Global Economic Factors and Events

On Friday, traders were likely to pay attention to US Federal Reserve head Jerome Powell’s remarks and a release of the central bank’s balance sheet. On the trade front, President Donald Trump announced he would delay for a month a proposed 25 percent tariff on most goods from Mexico after a conversation with that country’s president. That announcement came after Commerce Secretary Howard Lutnick said it was a strong likelihood that tariffs on Canada and Mexico would be postponed.

Disclaimer: This is not a recommendation to buy or sell a stock. 

To read the RA disclaimer, please click here